| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Dean A Wacker | |
| Keith J Miller | |||
| P433 | issue | 4 | |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 438-445 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Current Opinion in Drug Discovery and Development | Q15724606 |
| P1476 | title | Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases | |
| P478 | volume | 11 |
| Q38818675 | Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options |
| Q43186569 | Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists |
| Q46240693 | Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles |
| Q30478847 | HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia |
| Q34332000 | Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity |
| Q53251686 | Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective [Formula: see text] agonists. |
| Q34962263 | Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action |
| Q88061328 | Synthesis and Evaluation of Pyridyloxypyridyl Indole Carboxamides as Potential PET Imaging Agents for 5-HT2C Receptors |
| Q91749643 | Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development |
| Q35837700 | The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control |
| Q30462832 | The age of anxiety: role of animal models of anxiolytic action in drug discovery |
| Q24628661 | The impact of GPCR structures on pharmacology and structure-based drug design |
Search more.